Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2016-05-12
Product name:
TRANEXAMIC ACID INJECTION
DIN:
02454785
Product Monograph/Veterinary Labelling:
Date:
2019-09-26
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
METHAPHARM INC
81 Sinclair Blvd
Brantford
Ontario
Canada
N3S 7X6
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
20:28.16
Anatomical Therapeutic Chemical (ATC): See footnote 4
B02AA02 TRANEXAMIC ACID
Active ingredient group (AIG) number:See footnote5
0114760002
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| TRANEXAMIC ACID | 100 MG / ML |